UK ophthalmic laser market is growing at a CAGR of around 5.9% during the forecast period. As per the National Health System (NHS) UK, in UK, in 2018, there were almost 2 million people living with sight loss. Of these, around 360,000 are registered as blind or partially sighted. As per the National Center for Biotechnology Information (NCBI), in 2018, the leading cause of blindness is age-related macular degeneration, which affects more than 0.6 million people every year in UK. Glaucoma and cataract are other prevalent eye problems in the country.

Request a Free Sample of our UK Ophthalmic laser Market: https://www.omrglobal.com/request-sample/uk-ophthalmic-lasers-market

Sight loss and blindness from age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma and under-corrected refractive error are estimated to affect 1.93 million people in UK. As per the report of National Healthcare System in 2017, the mean waiting time for having a cataract surgery in the country is a period of 73 days. Thus, there is a large scope for the UK ophthalmic laser market owing to the presence of targeted pool of patients.

A full Report of UK Ophthalmic laser Market is Available at: https://www.omrglobal.com/industry-reports/uk-ophthalmic-lasers-market

The World Health Organization’s Vision 2020 program to eliminate preventable blindness by 2020 provides a strategic context for vision care service development. In 2017, UK stakeholders have developed a UK Vision Strategy inspired by the WHO’s initiative. The Department of Health is committed to supporting the aims of the UK Vision Strategy within the context of a locally commissioned service. The UK Vision Strategy aims to improve the eye health of the people of UKand to eliminate avoidable sight loss and deliver excellent support to those with visual impairment. In 2018, the number of people diagnosed with diabetes in UK was 3.5 million. These represent 6% of the UK population or 1 in every 16 people having diabetes.

However, there exist various new technologies in UK in terms of ophthalmology such as Astigmatic Keratotomy (AK), Automated Lamellar Keratoplasty (ALK), and Photorefractive Keratectomy (PRK) among others. Ophthalmic medical practitioners play only a minor role in ophthalmic laser surgery due to a very small number. The average cost of laser eye surgery in the UK is between $1,304 and $3,914 per eye. Irrespective of the cost of laser surgery, the increasing prevalence of eye problems will foster the growth of UK ophthalmic laser market.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-ophthalmic-lasers-market

UK Ophthalmic Laser Market Segmentation

By Type

• Excimer Laser
• Femtosecond Laser
• Cyclodiode Laser
• Nd: YAG Laser
• Selective-Laser-Trabeculoplasty (SLT) Laser
• Others

By Applications

• Cataract Surgery
• Glaucoma Surgery
• Diabetic Retinopathy
• Refractive Surgery
• Age-Related Macular Degeneration (AMD)
• Cornea Transplant Surgery
• Others

By End-User

• Hospital
• Clinic
• Ambulatory Surgical Center

Company Profiles

• Bausch & Lomb, Inc.
• Boston Scientific Corp.
• Carl Zeiss Meditec AG
• IPG Photonics Corp.
• Johnson & Johnson
• NIDEK Co., Ltd.
• Novartis International AG
• Ziemer Ophthalmic Systems AG

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404